Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
BEYOND GENOMiX logo — Proprietary multi-omics platform delivering actionable insig...

BEYOND GENOMiX

Proprietary multi-omics platform delivering actionable insights for age-related disease diagnostics and therapeutics

Founded 2023 Switzerland Neuchatel, Switzerland 4 employees Unknown AI, Biotechnology +1

General Information

Company Name BEYOND GENOMiX
Founded Year 2023
Location Switzerland Neuchatel, Switzerland +2
Employees 4
Industries AI, Biotechnology, Health Care
Funding Stage Unknown
Social

Get notified when BEYOND GENOMiX moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About BEYOND GENOMiX

BEYOND GENOMiX, founded in 2023, is a promising Swiss startup in the AI, Biotechnology, and Health Care industries. Located in Switzerland, this deeptech venture is carving a niche in the burgeoning field of age-related disease diagnostics and therapeutics.

The company's compelling slogan, "Proprietary multi-omics platform delivering actionable insights for age-related disease diagnostics and therapeutics," succinctly captures its mission to revolutionize healthcare. By leveraging aging hallmarks analysis, BEYOND GENOMiX not only diagnoses age-associated diseases but also contributes to drug discovery, positioning itself as a key player in age-associated health advancements.

The last investment noted was part of a Support Program on 01 January 2024, with participation from SWISS INVESTMENT CORPORATION, underscoring investor confidence and potential for growth. As the company moves forward, investor interest is likely to be spurred by its innovative approach and strategic industry placement.

Taxonomy: Proprietary Multi-Omics, Age-Related Disease Diagnostics, Therapeutics, Swiss Deeptech Start-up, Aging Hallmarks Analysis, Drug Discovery, MedTech, HealthTech, Precision Medicine, Age-Associated Diseases, Diagnostics

Services & Products

Genomics Pipeline Development
Telomere Analysis Technology
AI-powered Senescence Analysis
Multi-omics Data Generation
Machine Learning Insights
End-to-End Aging Hallmarks Analysis

Target Customers

Pharmaceutical Companies Biotechnology Researchers Healthcare Providers Diagnostics Companies Longevity Researchers

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Support Program •••••• 1
Investor
01 Jan 2024

BEYOND GENOMiX Alternatives & Competitors

View All Alternatives
BEYOND GENOMiX vs
Vandria SA
Vandria SA Switzerland

We develop first-in-class mitophagy inducers that rejuvenate cells to treat age-related and chronic...

Grant
14 employees
Manufacturing, Pharmaceutical
BEYOND GENOMiX vs
UNITY Biotechnology
UNITY Biotechnology United States

UNITY is harnessing pathways of aging biology to develop new medicines, with a focus on retinal dise...

Post Ipo Debt
33 employees
Biotechnology, Health Care
BEYOND GENOMiX vs
Ingenium Pharmaceuticals GmbH
Ingenium Pharmaceuticals GmbH

Ingenium Pharmaceuticals GmbH (Martinsried, Germany) is a fully owned subsidiary of Probiodrug AG (H...

Series Unknown
4 employees
Biotechnology
Also compare with: BEYOND GENOMiX vs Gero Gero BEYOND GENOMiX vs Juvena Therapeutics Juvena Therapeutics View all alternatives

FAQ About BEYOND GENOMiX

Proprietary multi-omics platform delivering actionable insights for age-related disease diagnostics and therapeutics
BEYOND GENOMiX was founded in 2023.
BEYOND GENOMiX is headquartered in Neuchatel, Switzerland.
BEYOND GENOMiX operates in the following industries: AI, Biotechnology, Health Care.
BEYOND GENOMiX has approximately 4 employees.
BEYOND GENOMiX has completed 1 funding round. The latest funding stage is Unknown.
BEYOND GENOMiX offers: Genomics Pipeline Development, Telomere Analysis Technology, AI-powered Senescence Analysis, Multi-omics Data Generation, Machine Learning Insights, End-to-End Aging Hallmarks Analysis.
Top alternatives and competitors to BEYOND GENOMiX include Vandria SA, UNITY Biotechnology, Ingenium Pharmaceuticals GmbH, Gero, Klogene Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BEYOND GENOMiX and Vandria SA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors BEYOND GENOMiX and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy